Table 1.

Baseline characteristics of the five treatment groups expressed as mean ± SD. No significant differences were found among groups for each reported parameter

N = 138	ABL-SC 80 μg n = 24		ABL-SC 40 μg n = 25		ABL-SC 20 μg n = 29		TPTD n = 31		Placebo n = 29
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age (years)	64.3	6.9	65.4	6.9	68.1	6.3	66.2	7.3	66.7	7.6
BMI (kg/m2)	25.6	3.4	26.1	3.9	26.4	2.7	26.7	3.1	25.5	3.3
Lumbar spine BMD (g/cm2)	0.765	0.111	0.752	0.080	0.767	0.103	0.762	0.096	0.796	0.102
Lumbar spine TBS	1.181	0.078	1.188	0.762	1.189	0.063	1.201	0.068	1.196	0.067

ABL-SC abaloparatide-SC, BMD bone mineral density, BMI body mass index, TBS trabecular bone score, TPTD teriparatide